AR and posterior cortical atrophy: Additionally, KB-0742 downregulates AR nascent transcription and disrupts AR-driven transcriptional programs and upstream master regulators (such as SOX4) in PCa.56,127 At an oral dose of 25–30 mg/kg daily, xenograft mouse models showed good tolerance and a significant reduction in tumor burden.56